Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Posts
- Category: important (continued)
- Category: IONIS-HTTRx
- 9th June, 2016 - Professor Sarah Tabrizi, Director of UCL’s Huntington’s Disease Centre, gives keynote speech at Google’s Zeitgeist event
- Discovery and Early Clinical Development of ISIS-HTTRx, the First HTT-Lowering Drug to Be Tested in Patients with Huntington’s Disease
- Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017
- EuroBuzz 2014: day two
- First Huntington's patients dosed with 'gene silencing' drug
- First Patient Enrolled in Pivotal Study of RG6042 (IONIS-HTT Rx) for People with Huntington's Disease
- How NOT to write a news article about a clinical trial
- Huntington's Disease Therapeutics Conference 2016 - day 2
- Ionis Phase I Huntington’s disease trial at halfway mark: ‘No surprises so far’ means good news
- IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease
- Liftoff: First humans treated with gene silencing drugs for HD!
- New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington's Disease
- Potential Treatment for Huntington's Disease, Found Effective, Safe in Mice, Monkeys, Enters Clinical Testing
- PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
- Roche announces details of its 'pivotal' huntingtin-lowering study
- Roche gears up for pivotal Phase 3 Huntington’s disease gene-silencing clinical trial
- Roche: less frequent dosing for Phase 3 Huntington’s clinical trial, easing burden on patients
- The best news for the Huntington's disease community since the discovery of the gene: Ionis trial data revealed, Roche confirms jump to Phase 3
- Category: Journals
- Even In Clinical Studies, Big Potential For MRI-Guided Procedures
- Exemplar Genetics and CHDI Foundation to Create Large Animal Models of Huntington’s Disease
- The Faces of Huntington's Disease - The Magazine - September 2012
- A Physician's Guide to the Management of Huntington's Disease -- 3rd Edition, 2012
- An Interview with Dr. Nancy Wexler: Discovering the Huntington Disease Gene
- August 2012 - The Faces of Huntington's Disease - The Magazine!
- Bee Brain Plasticity: Turning Back the Clock on Aging
- Behind the Scenes at EHDN
- Brain disorder study helps cure bid
- Breakthrough program halts Huntington’s progression
- Cell Contents May be Key to Controlling Toxicity of Huntington’s Disease Protein
- CHDI Foundation Selects Greenphire’s eClinicalGPS and ClinCard Technology Platforms to Establish Global Clinical Payment Capability
- Control of KMO gene expression in Alzheimer and Huntington diseases
- Device implanted in brain has therapeutic potential for Huntington's disease
- Dr. Jeff Carroll discusses family, research, being gene positive and HDBuzz
- Dr. Leslie Thompson Selected as First Editor of New Huntington’s Disease Journal
- EHDN News
- Enroll-HD Update
- Exercise increases cellular recycling
- Exon Skipping Prevents Formation of Toxic Protein Fragments in Huntington's Disease
- First treatment for Huntington's disease shows promise in rats, Van Andel Institute scientist says
- Four friends who experienced Huntington's Disease join bid to shed stigma surrounding condition
- Genetic testing: Does Kristen Powers have mom's fatal gene?
- GUIDA PRATICA ALL’ALIMENTAZIONE NELLA MALATTIA DI HUNTINGTON
- Guideline on Treating Chorea in Huntington Disease Published
- Hereditary Disease Foundation - Spring 2012 Issue 17
- Hospital freezer fault destroys crucial brain data
- Huntington's Disease: Our final documentary
- Huntington’s disease: how could stem cells help?
Plugin by dagondesign.com
